Current treatment strategies in brain metastases

Onkologie

Volumn 23, Issue 2, 2000, Pages 98-104

  Schackert, Gabriele ^a   Sobottka, S B ^b   Steinmetz, A ^b   Kirsch, M ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b NONE

Author keywords

Brain metastases; Chemotherapy; Radiosurgery; Radiotherapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

BLOOD BRAIN BARRIER; BRAIN METASTASIS; BRAIN SURGERY; CANCER CHEMOTHERAPY; CANCER SIZE; DRUG PENETRATION; DRUG SENSITIVITY; HUMAN; MULTIMODALITY CANCER THERAPY; PROGNOSIS; QUALITY OF LIFE; RADIOSURGERY; RECURRENT CANCER; REVIEW; SURVIVAL TIME; WHOLE BODY RADIATION;

EID: 0034030708     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000027080     Document Type: Review

References (77)

1. Posner JB: Management of brain metastases. Rev Neurol (Paris) 1992;148:477-487.
2. Cairncross JG, Posner JB: The management of brain metastases: in Walker MD (ed): Oncology of the Nervous System. Boston, MA; Nijhoff, 1983, pp 341-377.
3. Takakura K, Sano K, Hojo S, Hirano, A: Metastatic Tumors of the Central Nervous System. Tokyo, Igaku-Shoin, 1982.
4. Patchell RA: Brain metastases: in Black P, Loeffler JS (eds): Cancer of the Nervous System, chapt 35, 1997, Boston, Blackwell Science, pp 653-663.
5. Hammoud MA, McCutcheon IE, Elsouki R, Schoppa D, Patt YZ: Colorectal carcinoma and brain metastases: Distribution, treatment, and survival. Ann Surg Oncol 1996;3:453-463.
6. Young B, Patchell RA: Brain metastases: in Youmans JR: Neurological Surgery, ed 4. 1996, Philadelphia, Saunders pp 2748-2760.
7. Sartor K: MR Imaging of the Skull and Brain. Heidelberg, Springer. 1992, pp 317-326.
8. Peretti-Viton P, Margain D, Murayama N, Kadr I, Peragut JC: Brain metastases. J Neuroradiol 1991; 18:161-172.
9. Golfieri R, Cherryman GR, Olliff JF, Husband JE: Comparative evaluation of computerized tomography / magnetic resonance (1.5 T) in the detection of brain metastasis. Radiol Med (Torino) 1991;82:27-34.
10. Kuhn MJ, Hammer GM, Swenson LC, Youssef HT, Gleason TJ: MRI evaluation of 'solitary' brain metastases with triple-dose gadoteridol comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients. Comput Med Imaging Graph 1994;18: 391-399.
11. Vogl TJ, Friebe CE, Balzer T, Mack MG, Steiner S, Schedel H, Pegios W, Lanksch W, Banzer D, Felix R: Diagnosis with cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intraindividual evaluation of a phase II high dose study. Radiologe 1995;35:508-516.
12. Murakami K, Nawano S, Moriyama N, Sekiguchi R, Satake M, Fujimoto H, Ichikawa T: Intracranial metastases of hepatocellular carcinoma: CT and MRI. Neuroradiology 1996;38(suppl 1):31-35.
13. van de Pol M, van Oosterhout AG, Wilmik JT, ten-Velde GP, Twijnstra A: MRI in detection of brain metastases at initial staging of small-cell lung cancer. Neuroradiology 1996;38:207-210.
14. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500.
15. Smalley SR, Laws ER Jr. O'Fallon JR, Shaw EG, Schray MF: Resection of solitary brain metastasis. J Neurosurg 1992;77:531-540.
16. Delarive J, de Tribolet N: Cerebral metastases. A study of a surgical series of 81 cases. Neurochirurgie 1992;38:89-97.
17. Famell GF, Buckner JC, Cascino TL, O'Connell MJ, Schomberg PJ, Suman V: Brain metastases from colorectal carcinoma. The long term survivor. Cancer 1996;78:711-716.
18. Nieder C, Walter K, Nestle U, Schnabel K: Ten years disease-free survival after solitary brain metastasis from breast cancer. J Cancer Res Clin Oncol 1996; 122:570-572.
19. Sawaya R, Ligon BL, Bindal RK: Management of metastatic brain tumors. Ann Surg Oncol 1994;1: 169-178.
20. Galicich J, Arbit E: Metastatic brain tumors; in Youmans J (ed): Neurological Surgery, ed 3. Philadelphia, PA, Saunders, 1990, pp 3204-3222.
21. Patchell RA: Brain metastases. Neurol Clin 1991;9: 817-824.
22. Shu HKG, Sneed PK, Shiau CY, McDermott MW, Lamborn KR, Park E, Ho M, Petti PL, Smith V, Verhey LJ, Wara WM, Gutin PH, Larson DA: Factors influencing survival after gamma knife radiosurgery for patients with single and multiple brain metastases. Cancer J Sci Am 1996;2:335.
23. Bindal RK, Sawaya R, Leavens ME, Lee JJ: Surgical treatment of multiple brain metastases. J Neurosurg 1993;79:210-216.
24. Vermeulen SS: Whole brain radiotherapy in the treatment of metastatic brain tumors. Semin Surg Oncol 1998;14:64-69.
25. Nussbaum ES, Djalilian HR, Cho KH, Hall WA: Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 1996;78:1781-1788.
26. Wronski M, Arbit E, Burt M, Galicich JH: Survival after surgical treatment of brain metastases from lung cancer: A follow-up study of 231 patients treated between 1976 and 1991. J Neurosurg 1995; 83:605-616.
27. Weber F, Riedel A, Koning W, Menzel J: The role of adjuvant radiation and multiple resection within the surgical management of brain metastases. Neurosurg Rev 1996;19:23-32.
28. Wronski M, Arbit E, Russo P, Galicich JH: Surgical resection of brain metastases from renal cell carcinoma in 50 patients. Urology 1996;47:187-193.
29. Sneed PK, Larson DA, Wara WM: Radiotherapy for cerebral metastases. Neurosurg Clin N Am 1996;7: 505-515.
30. Borgelt B, Gelber R, Kramer S, Brady LW, Chang CH, Davis LW, Perez CA, Hendrickson FR: The palliation of brain metastases: Final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980;6:1-9.
31. Gelber RD, Larson M, Borgelt BB, Kramer S: Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis. Cancer 1981;48:1749-1753.
32. Hoskins PJ, Crow J, Ford HT: The influence of extent and local management on the outcome of radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys 1990;19:111-115.
33. Zimm S, Wampler GL, Stablein D, Hazra T, Young HF: Intracerebral metastases in solid-tumor patients: Natural history and results of treatment. Cancer 1981;48:384-394.
34. Epstein BE, Scott CB, Sause WT, Rotman M, Sneed PK, Janjan NA, Davis LW, Selim H, Mohiuddin M, Wasserman TH: Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater: Results of Radiation Oncology Group 85-28. Cancer 1993;71: 1362-1367.
35. Murray KJ, Scott C, Greenberg HM, Emami B, Seider M, Vora NL, Olson C, Whitton A, Movsas B, Curran W: A randomized phase III study of accelerated hyperfrationation versus standard in patients with unresected brain metastases: A report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 1997;39:571-574.
36. Andrews RJ, Gluck DS, Konchingeri RH: Surgical resection of brain metastases from lung cancer. Acta Neurochir (Wien) 1996;138:382-389.
37. Sawaya R, Ligon BL, Bindal AK, Bindal RK, Hess KR: Surgical treatment of metastatic brain tumors. J Neurooncol 1996;27:269-277.
38. Skibber JM, Soong SJ, Austin L, Balch CM, Sawaya RE: Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol 1996;3:118-123.
39. Mintz AH, Kestle J, Rathbone MP, Gaspar L, Hugenholtz H, Fisher B, Duncan G, Skingley P, Foster G, Levine M: A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with single cerebral metastasis. Cancer 1996;78:1470-1476.
40. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman, T, McKenna WG, Byhardt R: Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-751.
41. Breneman JC, Warnicke RE, Albright RE, Kukiatinant N, Shaw J, Armin D, Tew J Jr: Stereotactic radiosurgery for the treatment of brain metastases. Results of a single institution series. Cancer 1997;79:551-557.
42. Mehta MP, Rozental JM, Levin AB, Mackie TR, Kubsad SS, Gehring MA, Kinsella TJ: Defining the role of radiosurgery in the management of brain metastases. Int J Radiat Oncol Biol Phys 1992;24: 619-625.
43. Postmus PE, Haaxma-Reiche H, Gregor A, Groen HJ, Lewinski T, Scolard T, Kirkpatrick A, Curran D, Sahmoud T, Giaccone G: Brain-only metastases of small cell lung cancer: efficacy of whole brain radiotherapy. An EORTC phase II study. Radiother Oncol 1998;46:29-32.
44. Nieder C, Niewald M, Schnabel K: The results of the radiotherapy of brain metastases in patients at an advanced age. Strahlenther Onkol 1995;171. 646-648.
45. Kamath SS, McCarley DL, Zlotecki RA: Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer. Radiat Oncol Investig 1998;6: 226-232.
46. van de Pol M, ten Velde GP, Wilmink JT, Volovics A, Twijnstra A: Efficacy and safety of prophylactic cranial irradiation in patients with small cell lung cancer. J Neurooncol 1997;35:153-160.
47. Kiricuta IC, Bohndorf W: Adjuvant whole-brain irradiation in small-cell bronchial carcinoma. Strahlenther Onkol 1996;172:553-558.
48. Stiess J, Kiricuta IC, Müllr G, Bohndorf W: Usefulness of prophylactic whole brain irradiation in small cell bronchial carcinoma. Strahlenther Oncol 1995; 71:284-289.
49. DeAngelis LM, Delattre JY, Posner JB: Radiation-induced dementia in patients cured of brain metastases. Neurology 1989;39:789-796.
50. Paleologos NA, Imperato JP, Vick NA: Brain metastases: Effects of radiotherapy on long-term survivors. Neurology 1991;41(suppl 1):129.
51. Engenhart R, Kimmig BN, Hover KH, Wowra B, Romahn J, Lorenz WJ, van Kaick G, Wannenmacher M: Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer 1993;71:1353-1361.
52. Kihlström L, Karlsson B, Lindquist C: Gamma knife surgery for cerebral metastases. Implications for survival based on 16 years experience. Stereotact Funct Neurosurg 1993;61(suppl 1):45-50.
53. Kida Y, Kobayashi T, Tanaka T: Radiosurgery of the metastatic brain tumors with gamma knife. Acta Neurochir Suppl (Wien) 1995;63:89-94.
54. Alexander E III, Moriatry TM, Davis RB, Wen PY, Fine HA, Black PM, Kooy HM, Loeffler JS: Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 1995;87:34-40.
55. Voges J, Treuer H, Erdmann J, Schlegel W, Pastyr O, Müller RP, Sturm V: Linac Radiosurgery in Brain Metastases. Acta Neurochir 1994:62(suppl):72-76.
56. Seung SK, Shu HK, McDermott MW, Sneed PK, Larson DA: Stereotactic radiosurgery for malignant melanoma to the brain. Surg Clin North Am 1996;76:1399-1411.
57. Joseph J, Adler JR, Cox RS, Hancock SL: Linear accelerator-based stereotaxic radiosurgery for brain metastases: the influence of number of lesions on survival. J Clin Oncol 1996;14:1085-1092.
58. Valentino V: The results of radiosurgical management of 139 single cerebral metastases. Acta Neurochir Suppl (Wien) 1995;63:95-100.
59. Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman ML, Shaw EG, Hudgins WR, Weiner R, Harsh GR 4th, Sneed PK, Larson DA: A multiinstitutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 1994;28:797-802.
60. Rutigliano MJ, Lunsford LD, Kondziolka D. Strauss MJ, Khanna V, Green M: The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurg 1995;37:445-453.
61. Sturm V, Kober B, Höver KH, Schlegel W, Boesecke R, Pastyr O, Hartmann GH, Schabbert S, zum Winkel K, Kunze S, Lorenz WJ: Stereotactic percutaneous single dose irradiation of brain metastases with a linear accelerator. Int J Radial Oncol Biol Phys 1987;13:279-282.
62. Auchter RM, Lamond JP, Alexander III E, Noyes WR, Schultz CJ, Loeffler JS, Mehta MP: A multiinstitutional outcome and prognosis analysis of radio-surgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 1996;35:27-35.
63. Ostertag CB: Stereotaxic radiosurgery. Nervenarzt 1994;65:660-669.
64. Patchell RA, Cirrincione C, Thaler HT, Galicich JH, Kim J-H, Posner JB: Single brain metastases: surgery plus radiation or radiation alone. Neurology 1986;36: 447-453.
65. Bindal RK, Sawaya R, Leavens ME, Hess KR, Taylor SH: Reoperation for recurrent metastatic brain tumors. J Neurosurg 1995;83:600-604.
66. Arbit E, Wronski M, Burt M, Galicich JH: The treatment of patients with recurrent brain metastases. A retrospective analysis of 109 patients with non-small cell lung cancer. Cancer 1995;76:765-773.
67. Wong WW: Schild SE, Sawyer TE, Shaw EG: Analysis of outcome in patients reirradiated for brain metastases. Int J Radial Oncol Biol Phys 1996;34: 585-590.
68. Alexander E 3rd, Loeffler JS: Recurrent Brain metastases. Neurosurg Clin N Am 1996;7:517-526.
69. Shaw E, Scott C, Souhami L, Dinapoli R, Bahary JP, Kline R, Wharam M, Schultz C, Davey P, Loeffler J, Del-Rowe J, Marks L, Fisher B, Shin K: Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: Initial report of radiation therapy oncology group protocol. Int J Radiat Oncol Biol Phys 1996; 34:647-654.
70. Greig NH: Chemotherapy of brain metastases: current status. Cancer Treat Rev 1984;11:157-186.
71. Boogerd W, Dalesio O, Bais EM, van der Sande JJ: Response of brain metastases from breast cancer to systemic chemotherapy. Cancer 1992;69:972-980.
72. Twelves CJ, Souhami RL: Should cerebral melastases be treated by chemotherapy alone? Ann Oncol 1991:2:15-17.
73. Brocker EB, Bohndorf W, Kampgen E, Trcka J, Messer P, Tilgen W, Engenhart K, Flentje M: Fotemustine given simultaneously with total brain irradiation in multiple brain metastases of malignant melanoma: Report on a pilot study. Melanoma Res 1996;6:399-401.
74. Furuse K, Kamimori T, Kawahara M, Kodoma N, Ogawara M, Atagi S, Naka N, Akira M, Kubota K: A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplalin, vindesin and mitomyin in non-small-cell lung cancer brain metastasis. Br J Cancer 1997;75:614-618.
75. Stewart DJ: A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors. J Neurooncol 1994;20:121-139.
76. Kroll RA, Neuwelt EA: Outwilting the blood-brain barrier for therapeutic purposes: Osmotic opening and other means. Neurosurg 1998;42:1083-1099.
77. Bartus RT, Elliott PJ, Dean RL, Hayward NJ, Nagle TL, Huff MR, Snodgrass PA, Blunt DG: Controlled modulation of BBB permeability using the bradykinin agonist. RMP-7. Exp Neurol 1996;142:14-28.